journal article·2015-03-24

Combining Magnetic Hyperthermia and Photodynamic Therapy for Tumor Ablation with Photoresponsive Magnetic Liposomes

Riccardo Di Corato, Gaëlle Béalle, Jelena Kolosnjaj-Tabi, Ana Espinosa, Olivier Clément, Amanda K. A. Silva, Christine Ménager, Claire Wilhelm

ACS Nano· Volume 9· Issue 3
Publisher page

Abstract

The ongoing nanotech revolution has the potential to transform diagnostic and therapeutic methods. Stimuli-triggered nanotherapies based on remotely activated agents have become attractive alternatives to conventional chemotherapy. Herein, we designed an optimized smart nanoplatform based on dually loaded hybrid liposomes to achieve enhanced tumor therapy. The aqueous core was highly loaded with iron oxide nanoparticles, while the lipid bilayer was supplied with a photosensitizer payload. The double cargo translated into double functionality: generation of singlet oxygen under laser excitation and heat production under alternating magnetic field stimulation, coupling photodynamic therapy (PDT) to magnetic hyperthermia (MHT). These liposomes address both therapeutic agents within tumor cells, and the combined PDT/MHT therapy resulted in complete cancer cell death in vitro while total solid-tumor ablation was achieved in an in vivo rodent model.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Gold and Silver Nanoparticles Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Laboratoire Matière et Systèmes Complexes, UMR 7057, CNRS and University Paris Diderot, 75205 Paris cedex 13, France

Laboratoire PHENIX, Sorbonne Universités, UPMC, University Paris 06, UMR CNRS 8234, 4 place Jussieu 75005 Paris, France

Inserm U970, Paris Cardiovascular Research Center-PARCC/Université Paris-Descartes, 75006 Paris, France

Funding

European Commission

References (52)

Show source-provided references
1. Pavet V. · Oncogene · 2011 · 30 · 110.1038/onc.2010.460 ↗
2. Lee P. Y. · Curr. Drug Delivery · 2011 · 8 · 24510.2174/156720111795256110 ↗
3. Albini A. · J. Natl. Cancer Inst. · 2010 · 102 · 1410.1093/jnci/djp440 ↗
4. Bertrand N. · Adv. Drug Delivery Rev. · 2014 · 66 · 210.1016/j.addr.2013.11.009 ↗
5. Maherani B. · Curr. Nanosci. · 2011 · 7 · 43610.2174/157341311795542453 ↗
6. Torchilin V. P. · Biochim. Biophys. Acta, Biomembr. · 1994 · 1195 · 1110.1016/0005-2736(94)90003-5 ↗
7. Martina M. S. · Biomaterials · 2007 · 28 · 414310.1016/j.biomaterials.2007.05.025 ↗
8. Sawant R. R. · AAPS J. · 2012 · 14 · 30310.1208/s12248-012-9330-0 ↗
9. Peer D. · Nat. Nanotechnol. · 2007 · 2 · 75110.1038/nnano.2007.387 ↗
10. Chang H. I. · Int. J. Nanomed. · 2012 · 7 · 49
11. Ganta S. · J. Controlled Release · 2008 · 126 · 18710.1016/j.jconrel.2007.12.017 ↗
12. Brown S. B. · Lancet Oncol. · 2004 · 5 · 49710.1016/S1470-2045(04)01529-3 ↗
13. Tu H. L. · Adv. Mater. · 2009 · 21 · 17210.1002/adma.200800548 ↗
14. Taillefer J. · J. Pharm. Pharmacol. · 2001 · 53 · 15510.1211/0022357011775352 ↗
15. Fowley C. · Chem. Commun. · 2013 · 49 · 893410.1039/c3cc45181j ↗
16. Choi W. I. · ACS Nano · 2011 · 5 · 199510.1021/nn103047r ↗
17. Cole J. R. · J. Phys. Chem. C · 2009 · 113 · 1209010.1021/jp9003592 ↗
18. Zhang Z. · Adv. Mater. · 2013 · 25 · 386910.1002/adma.201301890 ↗
19. Schnarr K. · Adv. Healthcare Mater. · 2013 · 2 · 97610.1002/adhm.201300003 ↗
20. Shen H. F. · Adv. Healthcare Mater. · 2012 · 1 · 8410.1002/adhm.201100005 ↗
21. Johannsen M. · Int. J. Hyperthermia · 2005 · 21 · 63710.1080/02656730500158360 ↗
22. Shi D. · Adv. Mater. · 2009 · 21 · 217010.1002/adma.200803159 ↗
23. Brulé S. · Adv. Mater. · 2011 · 23 · 78710.1002/adma.201003763 ↗
24. Lopez-Noriega A. · Adv. Healthcare Mater. · 2014 · 3 · 85410.1002/adhm.201300649 ↗
25. Kolosnjaj-Tabi J. · ACS Nano · 2014 · 8 · 426810.1021/nn405356r ↗
26. Bovis M. J. · J. Controlled Release · 2012 · 157 · 19610.1016/j.jconrel.2011.09.085 ↗
27. Amstad E. · Nano Lett. · 2011 · 11 · 166410.1021/nl2001499 ↗
28. Soenen S. J. · Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. · 2011 · 3 · 197
29. Mikhaylov G. · Nat. Nanotechnol. · 2011 · 6 · 59410.1038/nnano.2011.112 ↗
30. Béalle G. · Langmuir · 2012 · 28 · 1183410.1021/la3024716 ↗
31. Yanase M. · Cancer Sci. · 1998 · 89 · 463
32. Pradhan P. · J. Controlled Release · 2010 · 142 · 10810.1016/j.jconrel.2009.10.002 ↗
33. Senge M. O. · Photochem. Photobiol. · 2011 · 87 · 124010.1111/j.1751-1097.2011.00986.x ↗
34. Karakullukcu B. · Head Neck · 2012 · 34 · 159710.1002/hed.21969 ↗
35. Fayol D. · Adv. Healthcare Mater. · 2013 · 2 · 31310.1002/adhm.201200294 ↗
36. Aubertin K. · PLoS One · 2013 · 8 · e8485010.1371/journal.pone.0084850 ↗
37. Das K. · Dyes Pigm. · 2005 · 64 · 20110.1016/j.dyepig.2004.05.009 ↗
38. Busch T. M. · Cancer Res. · 2000 · 60 · 2636
39. Orenstein A. · Photochem. Photobiol. · 1999 · 69 · 703
40. Yanase S. · Int. J. Oncol. · 2006 · 29 · 365
41. Frank J. · Int. J. Cancer · 2003 · 107 · 94110.1002/ijc.11507 ↗
42. Lin J. · ACS Nano · 2013 · 7 · 532010.1021/nn4011686 ↗
43. Jang B. · ACS Nano · 2011 · 5 · 108610.1021/nn102722z ↗
44. Wang J. · ACS Nano · 2012 · 6 · 507010.1021/nn300694v ↗
45. Wang S. · Adv. Mater. · 2013 · 25 · 305510.1002/adma.201204623 ↗
46. Oliveira D. M. · J. Magn. Magn. Mater. · 2005 · 289 · 47610.1016/j.jmmm.2004.11.134 ↗
47. Corr S. A. · Chem. Commun. · 2006 · 43 · 447410.1039/b610746j ↗
48. de Paula L. B. · J. Appl. Phys. · 2012 · 111 · 07B30710.1063/1.3671775 ↗
49. Bolfarini G. C. · J. Photochem. Photobiol., B · 2012 · 115 · 110.1016/j.jphotobiol.2012.05.009 ↗
50. Massart R. · IEEE Trans. Magn. · 1981 · 17 · 124710.1109/TMAG.1981.1061188 ↗
51. Szoka F. · Proc. Natl. Acad. Sci. U.S.A. · 1978 · 75 · 419410.1073/pnas.75.9.4194 ↗
52. Rouser G. · Lipids · 1970 · 5 · 49410.1007/BF02531316 ↗